Printer Friendly
The Free Library
14,650,700 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Neuro-4. Switching to eletriptan in migraineurs with unsatisfactory response to rizatriptan.


Switching medications due to lack of efficacy or tolerability is a common therapeutic strategy for optimizing treatment. Eletriptan and rizatriptan, while in the same therapeutic class, differ in pharmacokinetic characteristics that may influence their clinical efficacy in migraine migraine (mī`grān), headache characterized by recurrent attacks of severe pain, usually on one side of the head. It may be preceded by flashes or spots before the eyes or a ringing in the ears, and accompanied by double vision, nausea,  treatment. This study assessed treatment response to eletriptan 40 mg (E40) in migraineurs who were dissatisfied with rizatriptan. Patients (n = 123) meeting International Headache Society The International Headache Society (IHS) is a charity organisation founded in 1981 for people from all professions that are working to treat headache disorders.

It has over 1,000 ordinary members (including national society members).
 criteria for migraine3, with 1-6 attacks/month and who reported "unsatisfactory treatment response" to rizatriptan within the year were included in an open-label study. Migraineurs took E40 to treat one attack, and were allowed a second dose if the headache recurred within 2-24 hours. The primary outcome was the percentage of patients exhibiting a response to treatment (either mild headache or pain-free) at 2 hours, prior to any rescue medication. Reasons for dissatisfaction with rizatriptan included inadequate pain relief (84%), high recurrence rate (69%) and lack of improvement in associated symptoms (60%). The headache response rate at 2h following E40 treatment was 64%; 30% were pain-free. Compared with baseline, more patients were free from migraine-associated symptoms at 2 hours post-dose--without nausea (78%), photophobia photophobia /pho·to·pho·bia/ (-fo´be-ah) abnormal visual intolerance to light.photopho´bic

pho·to·pho·bi·a
n.
1.
 (72%) or phonophobia (77%). Within 2 hours, 63% of patients with baseline functional impairment (moderate or severe) had a functional response (return to reduced or normal activities). Further, 42% of patients experienced a sustained headache response through 24 hours post-dose. Seventy-two percent of patients considered eletriptan as good-to-excellent treatment; 78% reported overall satisfaction with the degree of headache relief. Results of this study suggest that eletriptan is an efficacious ef·fi·ca·cious  
adj.
Producing or capable of producing a desired effect. See Synonyms at effective.



[From Latin effic
 treatment option for patients who have unsatisfactory response to rizatriptan.

J. Goldstein, J. Denaro, C. Sikes Sikes can refer to: People
  • Bill Sikes, a fictional character from the novel, Oliver Twist, by Charles Dickens
  • Cynthia Sikes, actress
  • Dan Sikes, golfer
  • Stuart Sikes, recording engineer
Places
  • Sikes, Louisiana
, and P. Tiseo. San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden  Clinical Research Center, San Francisco, CA. Pfizer Inc, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY.
COPYRIGHT 2004 Southern Medical Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Section on Neurology
Author:Tiseo, P.
Publication:Southern Medical Journal
Date:Oct 1, 2004
Words:287
Previous Article:Neuro-3. Functional disability and reduction in quality of life associated with migraine in the primary care setting.(Section on Neurology)
Next Article:NS-1. Two level anterior fusion with stand-alone BAK-C cages.(Section on Neurosurgery)(Brief Article)
Topics:



Related Articles
My aching head. (interview with headache specialist Dr. Seymour Diamond) (Interview)
Headaches: the common malady: looking for more than an aspirin to fight off your headache? Here are some of the best online information sources we've...
Not "Financing a Sham". (Letters to the Editor).
A novel specific prophylaxis for menstrual-associated migraine.(Original Article)
Neuro-1. A rare case of Devic's syndrome in a 60 year-old female.(Section on Neurology)
Neuro-2. Early treatment of migraine: results of a prospective, double-blind, placebo-controlled trial using eletriptan.(Section on Neurology)
Neuro-3. Functional disability and reduction in quality of life associated with migraine in the primary care setting.(Section on Neurology)
Diagnosis and management of migraine headaches.(CME Topic)
The clinical properties of a Migrainous population in Eastern Turkey-Erzurum.(Original Article)
Migraines & women.(AGES & STAGES)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles